| Kelly Shea Davidson, MD | |
|
307 Boatner Rd Ste 112, Eglin Afb, FL 32542-1302 | |
| (850) 883-9394 | |
| Not Available |
| Full Name | Kelly Shea Davidson |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 8 Years |
| Location | 307 Boatner Rd Ste 112, Eglin Afb, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437508512 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | ME155854 (Florida) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sacred Heart Hospital On The Emerald Coast | Miramar beach, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ams Anesthetist Services Llc | 8325298458 | 144 |
News Archive
A new Harvey L. Neiman Health Policy Institute series of reports explores the impact of the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015, along with the Centers for Medicare and Medicaid Services' (CMS) 2016 proposal for its implementation, on radiologists.
Experiencing financial difficulties at university may increase the risk of female students developing an eating disorder, according to new research from the University of Southampton and Solent NHS Trust.
Molecular Insight Pharmaceuticals, Inc. today announced that it has completed an agreement to sub-license its Onalta™ brand 90-Y edotreotide radiotherapeutic in certain countries in Europe, the Middle East, North Africa, Russia and Turkey to BioMedica Life Sciences, S.A., Athens, Greece.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Scientific American magazine has published in its July issue an article entitled "DNA Drugs Come of Age." The article was co-authored by Dr. David Weiner, Chairman, Scientific Advisory Board, Inovio Pharmaceuticals, and Professor, Department of Pathology & Laboratory Medicine, at the University of Pennsylvania and Dr. Matthew Morrow, a post-doctorate research fellow at University of Pennsylvania.
The diverse functions of a special cell-recognition lipoprotein, LOX-1, weren't always fully understood. However, Baylor Research Institute investigators gained better insight into LOX-1's role in immune responses through a study recently published in Immunity. Investigators found that the lipoprotein promotes humoral responses, which could allow researchers to design effective vaccines against microbial infections, including influenza viruses and HIV.
› Verified 6 days ago
| Entity Name | Ams Anesthetist Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770834426 PECOS PAC ID: 8325298458 Enrollment ID: O20121025000224 |
News Archive
A new Harvey L. Neiman Health Policy Institute series of reports explores the impact of the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015, along with the Centers for Medicare and Medicaid Services' (CMS) 2016 proposal for its implementation, on radiologists.
Experiencing financial difficulties at university may increase the risk of female students developing an eating disorder, according to new research from the University of Southampton and Solent NHS Trust.
Molecular Insight Pharmaceuticals, Inc. today announced that it has completed an agreement to sub-license its Onalta™ brand 90-Y edotreotide radiotherapeutic in certain countries in Europe, the Middle East, North Africa, Russia and Turkey to BioMedica Life Sciences, S.A., Athens, Greece.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Scientific American magazine has published in its July issue an article entitled "DNA Drugs Come of Age." The article was co-authored by Dr. David Weiner, Chairman, Scientific Advisory Board, Inovio Pharmaceuticals, and Professor, Department of Pathology & Laboratory Medicine, at the University of Pennsylvania and Dr. Matthew Morrow, a post-doctorate research fellow at University of Pennsylvania.
The diverse functions of a special cell-recognition lipoprotein, LOX-1, weren't always fully understood. However, Baylor Research Institute investigators gained better insight into LOX-1's role in immune responses through a study recently published in Immunity. Investigators found that the lipoprotein promotes humoral responses, which could allow researchers to design effective vaccines against microbial infections, including influenza viruses and HIV.
› Verified 6 days ago
| Entity Name | Ams National Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316330830 PECOS PAC ID: 3870813025 Enrollment ID: O20150529000613 |
News Archive
A new Harvey L. Neiman Health Policy Institute series of reports explores the impact of the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015, along with the Centers for Medicare and Medicaid Services' (CMS) 2016 proposal for its implementation, on radiologists.
Experiencing financial difficulties at university may increase the risk of female students developing an eating disorder, according to new research from the University of Southampton and Solent NHS Trust.
Molecular Insight Pharmaceuticals, Inc. today announced that it has completed an agreement to sub-license its Onalta™ brand 90-Y edotreotide radiotherapeutic in certain countries in Europe, the Middle East, North Africa, Russia and Turkey to BioMedica Life Sciences, S.A., Athens, Greece.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Scientific American magazine has published in its July issue an article entitled "DNA Drugs Come of Age." The article was co-authored by Dr. David Weiner, Chairman, Scientific Advisory Board, Inovio Pharmaceuticals, and Professor, Department of Pathology & Laboratory Medicine, at the University of Pennsylvania and Dr. Matthew Morrow, a post-doctorate research fellow at University of Pennsylvania.
The diverse functions of a special cell-recognition lipoprotein, LOX-1, weren't always fully understood. However, Baylor Research Institute investigators gained better insight into LOX-1's role in immune responses through a study recently published in Immunity. Investigators found that the lipoprotein promotes humoral responses, which could allow researchers to design effective vaccines against microbial infections, including influenza viruses and HIV.
› Verified 6 days ago
| Entity Name | Anesthesia Physician Solutions Of North Florida Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164932901 PECOS PAC ID: 5597066001 Enrollment ID: O20151228002033 |
News Archive
A new Harvey L. Neiman Health Policy Institute series of reports explores the impact of the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015, along with the Centers for Medicare and Medicaid Services' (CMS) 2016 proposal for its implementation, on radiologists.
Experiencing financial difficulties at university may increase the risk of female students developing an eating disorder, according to new research from the University of Southampton and Solent NHS Trust.
Molecular Insight Pharmaceuticals, Inc. today announced that it has completed an agreement to sub-license its Onalta™ brand 90-Y edotreotide radiotherapeutic in certain countries in Europe, the Middle East, North Africa, Russia and Turkey to BioMedica Life Sciences, S.A., Athens, Greece.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Scientific American magazine has published in its July issue an article entitled "DNA Drugs Come of Age." The article was co-authored by Dr. David Weiner, Chairman, Scientific Advisory Board, Inovio Pharmaceuticals, and Professor, Department of Pathology & Laboratory Medicine, at the University of Pennsylvania and Dr. Matthew Morrow, a post-doctorate research fellow at University of Pennsylvania.
The diverse functions of a special cell-recognition lipoprotein, LOX-1, weren't always fully understood. However, Baylor Research Institute investigators gained better insight into LOX-1's role in immune responses through a study recently published in Immunity. Investigators found that the lipoprotein promotes humoral responses, which could allow researchers to design effective vaccines against microbial infections, including influenza viruses and HIV.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelly Shea Davidson, MD 307 Boatner Rd Ste 112, Eglin Afb, FL 32542-1302 Ph: (850) 883-9394 | Kelly Shea Davidson, MD 307 Boatner Rd Ste 112, Eglin Afb, FL 32542-1302 Ph: (850) 883-9394 |
News Archive
A new Harvey L. Neiman Health Policy Institute series of reports explores the impact of the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015, along with the Centers for Medicare and Medicaid Services' (CMS) 2016 proposal for its implementation, on radiologists.
Experiencing financial difficulties at university may increase the risk of female students developing an eating disorder, according to new research from the University of Southampton and Solent NHS Trust.
Molecular Insight Pharmaceuticals, Inc. today announced that it has completed an agreement to sub-license its Onalta™ brand 90-Y edotreotide radiotherapeutic in certain countries in Europe, the Middle East, North Africa, Russia and Turkey to BioMedica Life Sciences, S.A., Athens, Greece.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Scientific American magazine has published in its July issue an article entitled "DNA Drugs Come of Age." The article was co-authored by Dr. David Weiner, Chairman, Scientific Advisory Board, Inovio Pharmaceuticals, and Professor, Department of Pathology & Laboratory Medicine, at the University of Pennsylvania and Dr. Matthew Morrow, a post-doctorate research fellow at University of Pennsylvania.
The diverse functions of a special cell-recognition lipoprotein, LOX-1, weren't always fully understood. However, Baylor Research Institute investigators gained better insight into LOX-1's role in immune responses through a study recently published in Immunity. Investigators found that the lipoprotein promotes humoral responses, which could allow researchers to design effective vaccines against microbial infections, including influenza viruses and HIV.
› Verified 6 days ago
Dr. Andrew Keith Matthies, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 307 Boatner Rd Ste 114, Eglin Afb, FL 32542 Phone: 850-883-9394 | |
Dr. Charles Dale Williams Ii, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 96mdg, 307 Boatner Road, Ste 113, Eglin Afb, FL 32542 Phone: 850-883-9957 | |
Dr. Megan Kristine Barnett, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 307 Boatner Rd, Anesthesia Dept, Eglin Afb, FL 32542 Phone: 559-906-1390 | |
Dr. Jamison Wendell Elder, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 307 Boatner Rd, Eglin Afb, FL 32542 Phone: 803-840-0825 | |
Dr. Eric F Holt, D.O. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 307 Boatner Rd, Eglin Afb, FL 32542 Phone: 850-883-9392 | |
Jeffrey Scott Burbidge, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 307 Boatner Rd, Suite 114, Eglin Afb, FL 32542 Phone: 850-883-9506 | |
Brandon Samuel Lerner, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 307 Boatner Rd Ste 114, Eglin Afb, FL 32542 Phone: 770-310-0334 |